Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial - Couturaud, F; Schmidt, J; Sanchez, O; RENOVE Investigators (Lancet, 2025)
(10480):